特刊编辑寄语：“胶质母细胞瘤：重现关键突破与未来展望”。
Editorial to Special Issue "Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective".
机构信息
Department of Stereotactic and Functional Neurosurgery, University Hospital of Bonn, 53127 Bonn, Germany.
Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
出版信息
Int J Mol Sci. 2023 Jan 29;24(3):2548. doi: 10.3390/ijms24032548.
Abstract
Glioblastoma (GBM) remains the most common and aggressive malignant primary brain tumor [...].
摘要
胶质母细胞瘤（GBM）仍然是最常见和最具侵袭性的恶性原发性脑肿瘤[...]。
相似文献
1
Editorial to Special Issue "Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective".特刊编辑寄语：“胶质母细胞瘤：重现关键突破与未来展望”。
Int J Mol Sci. 2023 Jan 29;24(3):2548. doi: 10.3390/ijms24032548.
2
An update on the epigenetics of glioblastomas.胶质母细胞瘤表观遗传学的最新进展。
Epigenomics. 2016 Sep;8(9):1289-305. doi: 10.2217/epi-2016-0040. Epub 2016 Sep 2.
3
Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.广泛转移的胶质母细胞瘤伴 BRCA1 和 ARID1A 突变：一例报告。
BMC Cancer. 2020 Jan 20;20(1):47. doi: 10.1186/s12885-020-6540-1.
4
MicroRNAs in human glioblastoma: from bench to beside.人类脑胶质瘤中的 microRNAs：从基础到临床。
Front Biosci (Landmark Ed). 2015 Jan 1;20(1):105-18. doi: 10.2741/4300.
5
Perspective of mesenchymal transformation in glioblastoma.胶质母细胞瘤中间质转化的观点。
Acta Neuropathol Commun. 2021 Mar 24;9(1):50. doi: 10.1186/s40478-021-01151-4.
6
Recognizing and correcting failures in glioblastoma treatment.识别和纠正胶质母细胞瘤治疗中的失败。
Cancer Invest. 2014 Jul;32(6):299-302. doi: 10.3109/07357907.2014.909827. Epub 2014 Apr 25.
7
Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.半乳糖凝集素-1 是一种在肿瘤边缘优先表达的基因，可促进神经胶质瘤细胞的侵袭。
Mol Cancer. 2012 May 14;11:32. doi: 10.1186/1476-4598-11-32.
8
Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.Brahma 相关基因-1（BRG1）促进神经胶质瘤细胞的恶性表型。
J Cell Mol Med. 2021 Mar;25(6):2956-2966. doi: 10.1111/jcmm.16330. Epub 2021 Feb 2.
9
MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.《胶质母细胞瘤发病机制与治疗中的 microRNAs：全面综述》。
Crit Rev Oncol Hematol. 2017 Dec;120:22-33. doi: 10.1016/j.critrevonc.2017.10.003. Epub 2017 Oct 7.
10
Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.胶质母细胞瘤及胶质母细胞瘤来源的脑肿瘤起始细胞中CD97亚型的比例上调。
PLoS One. 2015 Feb 25;10(2):e0111532. doi: 10.1371/journal.pone.0111532. eCollection 2015.
引用本文的文献
1
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma.树突状细胞-细胞因子诱导的杀伤细胞（DC-CIK）作为治疗胶质母细胞瘤潜在有效免疫治疗模型的临床前评估。
Sci Rep. 2025 Jan 3;15(1):734. doi: 10.1038/s41598-024-84284-5.
本文引用的文献
1
TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.TRPML2黏脂通道驱动胶质瘤干细胞对替莫唑胺的反应并影响胶质母细胞瘤患者的总生存期。
Int J Mol Sci. 2022 Dec 5;23(23):15356. doi: 10.3390/ijms232315356.
2
The Chromatin-Oxygen Sensor Gene Associates with Novel Hypoxia-Related Signatures in Glioblastoma Multiforme.染色质-氧传感器基因与胶质母细胞瘤中新型缺氧相关特征相关联。
Int J Mol Sci. 2022 Sep 6;23(18):10250. doi: 10.3390/ijms231810250.
3
Protein Quality Control in Glioblastoma: A Review of the Current Literature with New Perspectives on Therapeutic Targets.脑胶质瘤中的蛋白质质量控制：对现有文献的综述及治疗靶点的新视角。
Int J Mol Sci. 2022 Aug 27;23(17):9734. doi: 10.3390/ijms23179734.
4
Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients.TRPML1 和 TRPML2 黏液素通道的共表达影响胶质母细胞瘤患者的生存。
Int J Mol Sci. 2022 Jul 13;23(14):7741. doi: 10.3390/ijms23147741.
5
Molecular and Circulating Biomarkers in Patients with Glioblastoma.胶质母细胞瘤患者的分子和循环生物标志物。
Int J Mol Sci. 2022 Jul 5;23(13):7474. doi: 10.3390/ijms23137474.
6
Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.基于算法重建分子途径的人类神经胶质瘤下一代分级和生存表达生物标志物。
Int J Mol Sci. 2022 Jun 30;23(13):7330. doi: 10.3390/ijms23137330.
7
Glioblastoma Treatment: State-of-the-Art and Future Perspectives.胶质母细胞瘤治疗：现状与未来展望。
Int J Mol Sci. 2022 Jun 29;23(13):7207. doi: 10.3390/ijms23137207.
8
Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia.慢性辐射暴露的胶质母细胞瘤细胞在低氧条件下对 Chk1 抑制的反应较差。
Int J Mol Sci. 2022 Jun 24;23(13):7051. doi: 10.3390/ijms23137051.
9
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.胶质母细胞瘤的免疫治疗：当前方法与未来展望。
Int J Mol Sci. 2022 Jun 24;23(13):7046. doi: 10.3390/ijms23137046.
10
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.糖基化-凝集素相互作用作为胶质母细胞瘤新型免疫抑制驱动因素。
Int J Mol Sci. 2022 Jun 5;23(11):6312. doi: 10.3390/ijms23116312.
Zotero 插件